These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
506 related articles for article (PubMed ID: 28920756)
21. Comprehensive evaluation of androgen replacement therapy in aging Japanese men with late-onset hypogonadism. Okada K; Yamaguchi K; Chiba K; Miyake H; Fujisawa M Aging Male; 2014 Jun; 17(2):72-5. PubMed ID: 24533913 [TBL] [Abstract][Full Text] [Related]
22. Symptomatic response to testosterone treatment in dieting obese men with low testosterone levels in a randomized, placebo-controlled clinical trial. Ng Tang Fui M; Hoermann R; Prendergast LA; Zajac JD; Grossmann M Int J Obes (Lond); 2017 Mar; 41(3):420-426. PubMed ID: 28028318 [TBL] [Abstract][Full Text] [Related]
23. Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30-week randomized placebo-controlled study. Hackett G; Cole N; Saghir A; Jones P; Strange RC; Ramachandran S Andrology; 2017 Sep; 5(5):905-913. PubMed ID: 28771964 [TBL] [Abstract][Full Text] [Related]
24. Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone. Reyes-Vallejo L; Lazarou S; Morgentaler A J Sex Med; 2007 Nov; 4(6):1757-62. PubMed ID: 17087806 [TBL] [Abstract][Full Text] [Related]
25. Effects of intermission and resumption of long-term testosterone replacement therapy on body weight and metabolic parameters in hypogonadal in middle-aged and elderly men. Yassin A; Almehmadi Y; Saad F; Doros G; Gooren L Clin Endocrinol (Oxf); 2016 Jan; 84(1):107-14. PubMed ID: 26331709 [TBL] [Abstract][Full Text] [Related]
26. Androgen receptor gene CAG repeat polymorphism independently influences recovery of male sexual function after testosterone replacement therapy in postsurgical hypogonadotropic hypogonadism. Tirabassi G; Delli Muti N; Corona G; Maggi M; Balercia G J Sex Med; 2014 May; 11(5):1302-8. PubMed ID: 24593124 [TBL] [Abstract][Full Text] [Related]
27. Effects of testosterone replacement therapy on hypogonadal men with osteopenia or osteoporosis: a subanalysis of a prospective randomized controlled study in Japan (EARTH study). Shigehara K; Konaka H; Koh E; Nakashima K; Iijima M; Nohara T; Izumi K; Kitagawa Y; Kadono Y; Sugimoto K; Iwamoto T; Mizokami A; Namiki M Aging Male; 2017 Sep; 20(3):139-145. PubMed ID: 28347184 [TBL] [Abstract][Full Text] [Related]
28. Effects of two-year testosterone replacement therapy on cognition, emotions and quality of life in young and middle-aged hypogonadal men. Lašaitė L; Čeponis J; Preikša RT; Žilaitienė B Andrologia; 2017 Apr; 49(3):. PubMed ID: 27545990 [TBL] [Abstract][Full Text] [Related]
30. The effects of treating male hypogonadism on couples' sexual desire and function. Conaglen JV; Conaglen HM J Sex Med; 2009 Feb; 6(2):456-63. PubMed ID: 19215616 [TBL] [Abstract][Full Text] [Related]
31. Treatment of 161 men with symptomatic late onset hypogonadism with long-acting parenteral testosterone undecanoate: effects on body composition, lipids, and psychosexual complaints. Permpongkosol S; Tantirangsee N; Ratana-olarn K J Sex Med; 2010 Nov; 7(11):3765-74. PubMed ID: 20807330 [TBL] [Abstract][Full Text] [Related]
32. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy. Coward RM; Simhan J; Carson CC BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450 [TBL] [Abstract][Full Text] [Related]
33. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy. Grober ED; Lamb DJ; Khera M; Murthy L; Lipshultz LI Int J Impot Res; 2008; 20(6):561-5. PubMed ID: 18843272 [TBL] [Abstract][Full Text] [Related]
34. The Effect of Testosterone Replacement Therapy on Penile Hemodynamics in Hypogonadal Men With Erectile Dysfunction, Having Veno-Occlusive Dysfunction. Efesoy O; Çayan S; Akbay E Am J Mens Health; 2018 May; 12(3):634-638. PubMed ID: 29575969 [TBL] [Abstract][Full Text] [Related]
35. Long-Term Testosterone Therapy Improves Urinary and Sexual Function, and Quality of Life in Men with Hypogonadism: Results from a Propensity Matched Subgroup of a Controlled Registry Study. Haider KS; Haider A; Doros G; Traish A J Urol; 2018 Jan; 199(1):257-265. PubMed ID: 28728990 [TBL] [Abstract][Full Text] [Related]
36. Early weight loss predicts the reduction of obesity in men with erectile dysfunction and hypogonadism undergoing long-term testosterone replacement therapy. Salman M; Yassin DJ; Shoukfeh H; Nettleship JE; Yassin A Aging Male; 2017 Mar; 20(1):45-48. PubMed ID: 28084147 [TBL] [Abstract][Full Text] [Related]
37. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report. Morrison BF; Reid M; Madden W; Burnett AL Andrology; 2013 Jul; 1(4):576-82. PubMed ID: 23606509 [TBL] [Abstract][Full Text] [Related]
38. Testosterone replacement therapy improves health-related quality of life for patients with late-onset hypogonadism: a meta-analysis of randomized controlled trials. Nian Y; Ding M; Hu S; He H; Cheng S; Yi L; Li Y; Wang Y Andrologia; 2017 May; 49(4):. PubMed ID: 27389320 [TBL] [Abstract][Full Text] [Related]
39. EMAS position statement: Testosterone replacement therapy in older men. Kanakis GA; Pofi R; Goulis DG; Isidori AM; Armeni E; Erel CT; Fistonić I; Hillard T; Hirschberg AL; Meczekalski B; Mendoza N; Mueck AO; Simoncini T; Stute P; van Dijken D; Rees M; Lambrinoudaki I Maturitas; 2023 Dec; 178():107854. PubMed ID: 37845136 [TBL] [Abstract][Full Text] [Related]
40. Demographic and Clinical Correlates of Patient-Reported Improvement in Sex Drive, Erectile Function, and Energy With Testosterone Solution 2. Wu F; Zitzmann M; Heiselman D; Donatucci C; Knorr J; Patel AB; Kinchen K J Sex Med; 2016 Aug; 13(8):1212-9. PubMed ID: 27329542 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]